US Stock MarketDetailed Quotes
CNSP CNS Pharmaceuticals
- 0.1277
- +0.0077+6.42%
Trading Nov 19 11:38 ET
7.34MMarket Cap-2P/E (TTM)
0.1290High0.1126Low3.70MVolume0.1150Open0.1200Pre Close452.38KTurnover6.56%Turnover Ratio0.00P/E (Static)57.49MShares118.995052wk High2.20P/B7.20MFloat Cap0.095552wk Low--Dividend TTM56.38MShs Float8534.8500Historical High--Div YieldTTM13.67%Amplitude0.0950Historical Low0.1220Avg Price1Lot Size
About CNS Pharmaceuticals Company
CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12. The company was founded by Waldemar Priebe in July 2017 and is headquartered in Houston, TX.
Company Profile
SymbolCNSP
Company NameCNS Pharmaceuticals
Listing DateNov 8, 2019
Issue Price4.00
Founded2017
CEOMr. John M. Climaco
MarketNASDAQ
Employees5
Fiscal Year Ends12-31
Address2100 West Loop South,Suite 900
CityHouston
ProvinceTexas
CountryUnited States of America
Zip Code77027
Phone1-800-946-9185
Websitehttp://www.cnspharma.com
Company Executives
- Name
- Position
- Salary
- John M. Climaco
- President, Chief Executive Officer and Director
- 624.35K
- Dr. Sandra L. Silberman, PhD
- Chief Medical Officer
- 270.15K
- Christopher Downs
- Chief Financial Officer and Principal Accounting Officer
- 401.52K
- Dr. Donald H. Picker, PhD
- Chief Science Officer
- --
- Faith L. Charles
- Chairman of the Board
- 112.64K
- Dr. Jerzy Gumulka
- Independent Director
- 115.16K
- Jeffry R. Keyes
- Independent Director
- 135.46K
- Bettina M. Cockroft
- Independent Director
- 58.31K
- Carl Evans
- Independent Director
- 114.96K
- Amy Mahery
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
